- Home
- »
- Pharmaceuticals
- »
-
New York Legal Cannabis Market Size, Industry Report, 2033GVR Report cover
New York Legal Cannabis Market (2026 - 2033) Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation), By End Use, And Segment Forecasts
- Report ID: GVR-3-68038-420-8
- Number of Report Pages: 80
- Format: PDF
- Historical Range: 2021 - 2025
- Forecast Period: 2026 - 2033
- Industry: Healthcare
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
New York Legal Cannabis Market Summary
The New York legal cannabis market size was estimated at USD 2.52 billion in 2025 and is expected to reach USD 6.06 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market growth is driven by the legalization of cannabis, increasing awareness regarding the therapeutic benefits of cannabis-based products, and the rising use of cannabis for both medical and recreational purposes.
Key Market Trends & Insights
- By source, the marijuana segment dominated the market in 2025.
- By cultivation, the indoor cultivation segment held the maximum market share of 57.2% in 2025.
- By Derivatives, the CBD segment held the largest market share of 59.5% in 2025.
- By end use, the recreational use segment held the maximum market share of 66.7% in 2025.
Market Size & Forecast
- 2025 Market Size: USD 2.52 Billion
- 2033 Projected Market Size: USD 6.06 Billion
- CAGR (2026-2033): 11.5%
For instance, in January 2026, the state witnessed rapid retail expansion, with the number of licensed cannabis retailers increasing to 556 by the end of 2025, up from 261 in 2024, with more than 200 stores concentrated in New York City, reflecting strong market penetration and improving legal access.
Market Drivers
Growing Adoption of Cannabis for Treatment of Chronic Diseases
The rising prevalence of chronic diseases, particularly cancer, is a major factor driving the adoption of medical cannabis in New York. Patients are increasingly turning to cannabis based therapies for managing symptoms such as chronic pain, nausea, and anxiety associated with long term conditions. The ongoing increase in the legalization and acceptance of medical cannabis products has led to market growth. For instance, the U.S. Food and Drug Administration (FDA) has approved Marinol and Syndros, a cannabis-derived drug product, for the treatment of nausea associated with cancer chemotherapy and anorexia associated with weight loss in AIDS patients.
Growing demand for CBD-based products
A positive attitude of consumers towards the consumption of cannabis and cannabinoid (CBD) based products led to the rise in demand for cannabis-based products. This growth is driven by increasing legalization, normalization, and awareness of wellness benefits. The expansion of product formats such as edibles, beverages, vapes, and CBD-infused wellness products has further enhanced accessibility and appeal across diverse consumer segments. For instance, in November 2023 cannabis lifestyle brand Cookies announced the launch of select vape and infused pre-roll products in the New York market.
“Launching Cookies products in New York is a dream come true for me. I love this city and we have been working hard to get products to the Big Apple. Now that the local regulators have allowed us to do so, we have been working nonstop to bring our authentic products to the state, and to finally be able to do so through our partnership with Final Bell, is exciting. I can't wait to have Cookies products in the hands of the NY cannabis connoisseurs and spoil the lungs of customers.”
-Co-Founder and CEO of Cookies
Structured Regulatory Framework and Supportive Reimbursement Policies Market
The structured regulatory framework and supportive policy environment in New York have significantly contributed to the growth of the cannabis and CBD market by enhancing accessibility, ensuring product safety, and strengthening consumer confidence. Supportive healthcare policies enhance this framework by increasing access of patients to medical cannabis. The New York State Medical Cannabis Program allows certified healthcare providers to prescribe cannabis-based treatments. The guidelines focus on increasing access to cannabis therapies and promoting physician involvement, which leads to an increase in thetherapeutic applications of cannabis.

New York Legal Cannabis Consumption Trends
Legal cannabis consumption in New York is experiencing steady growth, supported by increasing social acceptance and the gradual expansion of licensed dispensaries.
-
Product Preferences: Growing demand for edibles, vapes, and pre-rolls alongside traditional flower, with a shift toward convenient and discreet formats
-
Usage Trends: Increasing adoption for wellness purposes such as stress relief, sleep support, and lifestyle use beyond recreational consumption
-
Market Shift: Gradual transition from illicit to legal channels as product quality, safety, and regulatory clarity improve
-
Consumer Segmentation: Entry of new users alongside experienced consumers exploring premium, specialized, and higher-value products
-
Retail Expansion Impact: Increasing number of dispensaries improving accessibility and supporting sustained consumption growth
Market Concentration & Characteristics
The New York legal cannabis market is characterized by a high degree of innovation. Factors such as increasing R&D activities on the use of cannabis and its medicinal properties, growing awareness among people regarding the medicinal benefits of cannabis, and rising demand for cannabis-infused products are fostering research activities on cannabis. For instance, NYU Grossman School of Medicine's Department of Psychiatry, a medical school in New York, is conducting research on cannabidiol as a potential treatment for psychiatric disorders.
New York legal cannabis is characterized by a medium level of mergers and acquisitions (M&A). Several market players are acquiring smaller players to strengthen their market positions. This strategy enables companies to increase their capabilities, expand product portfolios, and improve competencies.

The cannabis industry in New York is flourishing due to a structured regulatory framework for the consumption, cultivation, and sale of cannabis. In New York, The New York State Office of Cannabis Management (OCM) licenses processors, cultivators, dispensaries, and distributors to cultivate and sell cannabis. In November 2025,the New York State Office of Cannabis Management (OCM) announced the opening of the 500th licensed adult-use cannabis dispensary in the state. This emphasizes the state’s structured licensing system.
Many companies are adopting this strategy to strengthen their business and expand their product portfolio. For instance, in May 2025, Curaleaf introduced Select FormulaX THC energy drink and Select ACE vape technology, strengthening its innovation pipeline in beverages and vape categories.
Source Insights
The marijuana segment dominated the market with the largest revenue share in 2025 and is anticipated to witness the fastest CAGR over the forecast period. The market for marijuana in New York is anticipated to increase owing to growing awareness regarding its therapeutic applications, such as eye pressure reduction, appetite enhancement, and pain management. Moreover, changing consumer behavior toward recreational marijuana and introducing educational programs for cannabis cultivation and its medical properties fuel the market growth. For instance, in April 2025, New York State Office of Cannabis Management in collaboration with New York State Department of Labor launched “Responsible Workforce Training Program” aimed at educating cannabis workers on product safety, regulatory compliance, and workforce standard .
The hemp segment held a significant revenue share in 2025 due to the increasing awareness of the levels of CBD present in it. This led to a rise in demand for hemp extracts across various industries such as cosmetics, personal care, food and beverages, nutraceuticals, pharmaceuticals, textiles, and non-textiles. Consumers are increasingly adopting cannabis in various non-textile applications to reduce deforestation, pollution, and non-biodegradable waste. For instance, New York Hemp Oil is the only USDA Certified Organic hemp company in New York State which offers hemp-based CBD products like Oils.
Derivatives Insights
The CBD segment dominated the market with the largest revenue share of 59.5% in 2025. Due to the rise in demand for various CBD-infused products, including cannabis oil, beauty products, gummies, beverages, capsules, etc., boosted the market growth in the state. CBD enters the human body in different ways, such as vaping, smoking, and, topically, through the skin. CBD is utilized to produce medical drugs and medical drugs personal care products. For instance, Beautyque NYC, a New York Cannabis cosmetics company, offers various products such as CBD Tinted Moisturizer, CBD Collagen Boost Serum, CBD Activated Charcoal Cleanser, CBD Men's Moisturizer, and many more.
The other segment held a significant market share in 2025 and is anticipated to grow at the fastest CAGR over the forecast period. This segment includes elements of the cannabis plant, such as terpenes, flavonoids, and other minor cannabinoids (CBN, CBG, THCV). Various advantages offered by these minor cannabinoids and terpenes in treating various medical conditions and introducing new products are propelling the market growth. For instanc , in July 2024, Grön, a manufacturer of cannabis-infused edibles, launched its full lineup of MEGA flavors and Sugar-Coated Pearls in New York. The Sugar-Coated Pearls include Blackberry Lemonade (1:1:2 CBN/CBD/THC, Indica), Blueberry Lemonade (3:1 CBG/THC, sativa), Pomegranate (4:1 CBD/THC, hybrid), Raspberry Lemonade (sativa), Tangelo (2:1:1 THC/CBC/CBG, sativa), Peach Prosecco (1:1 CBD/THC, hybrid), Tart Cherry (10:1 CBN/THC, indica), and Watermelon (indica).
Cultivation Insights
The indoor cultivation segment led the market with the largest revenue share of 57.2% in 2025 and is expected to grow at the fastest CAGR over the forecast period. The introduction of new indoor cannabis cultivation facilities and favorable government initiatives drive the market growth.For instance, in June 2024, New York state-approved home cannabis cultivation, permitting adults to cultivate their own plants. The New York State Cannabis Control Board approved and adopted regulations allowing adults aged 21 and above to grow cannabis plants at home.
The outdoor cultivation segment held a significant share in 2025. Cultivating cannabis in an outdoor setting is generally more cost-effective than indoor cultivation, owing to the presence of essential growth elements in the natural environment. This advantage has led to an increase in outdoor cultivation activities, as it mitigates the requirement for expensive agricultural infrastructure and reduces operational expenditures, thereby accelerating segment growth.
End Use Insights
The recreational use segment dominated the market in 2025 with a revenue share of 66.7% and is expected to grow at the fastest CAGR over the forecast period. Recreational use of cannabis includes smoking and consuming it in the form of foods & beverages, vapes, and gummies. Moreover, the legalization of cannabis for recreational purposes and the increase in the launch of new cannabis-based food products boost the segment's growth. For instance, in February 2023, Cycling Frog, a provider of cannabis products, collaborated with Gasko & Meyer, New York-based beverage distributors, to bring its THC and CBD products to New York.

The medical use segment is anticipated to grow significantly over the forecast period. The medical application of cannabis has witnessed major growth as the number of scientific studies supporting its benefits in the treatment of various diseases has increased. Psychological conditions such as anxiety disorders, PTSD, bipolar disorder, depression, ADHD, multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease can be effectively treated with medical cannabis, owing to its therapeutic benefits. Thus, such factors fuel the segment's growth.
Key New York Legal Cannabis Company Insights
The growing demand for cannabis-infused cosmetics and food items is anticipated to propel the entry of new companies into the market. Key market players engage in strategic alliances such as mergers & acquisitions, collaborations, partnerships, and product launches with other industry participants to expand their market presence.
Key New York Legal Cannabis Companies:
- Curaleaf Holdings, Inc.
- New York Hemp Oil
- COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC.
- ACREAGE HOLDINGS.
- Cannabist Company Holdings Inc.
- Cresco Labs.
- PharmaCann Inc.
- Vireo Health International, Inc.
- Green Thumb Industries (GTI)
- Tilray Brands, Inc.
Recent Developments
-
In March 2026, Curaleaf introduced the Select Briq 2 vape device, featuring advanced Flavor Protection Technology and Meter Mode Intelligence to enhance flavor consistency, reduce clogging, and enable real-time dose tracking, reinforcing its leadership in the premium vape segment.
-
In October 2025, Raw Garden launched live resin infused joints, combining high-quality cannabis flower with refined live resin concentrates to deliver a smooth, potent, and consistent smoking experience, expanding its presence in the premium infused pre-roll segment.
-
In May 2025, Curaleaf Holdings, Inc. expanded its Select brand portfolio by introducing new THC-infused nano beverage enhancers, designed for convenient mixing with drinks, targeting growing demand for recreational cannabis beverages.
-
In May 2025, Curaleaf introduced Select FormulaX THC energy drink and Select ACE vape technology, strengthening its innovation pipeline in beverages and vape categories
New York Legal Cannabis Market Report Scope
Report Attribute
Details
Market size value in 2026
USD 2.82 billion
Revenue forecast in 2033
USD 6.06 billion
Growth rate
CAGR of 11.5% from 2026 to 2033
Actual data
2021 - 2025
Forecast data
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Source, derivatives, cultivation, end use
State scope
New York
Key companies profiled
Curaleaf Holdings, Inc.; New York Hemp Oil; COOKIES CREATIVE PRODUCTIONS & CONSULTING INC.; ACREAGE HOLDINGS.; Cannabist Company Holdings Inc.; Cresco Labs.; PharmaCann Inc.; Vireo Health International, Inc.; Green Thumb Industries (GTI); Tilray Brands, Inc
Customization scope
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
New York Legal Cannabis Market Report Segmentation
This report forecasts revenue growth and provides at country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the New York legal cannabis market report based on source, derivatives, cultivation, and end use:
-
Source Outlook (Revenue, USD Million, 2021 - 2033)
-
Hemp
-
Hemp Oil
-
Industrial Hemp
-
-
Marijuana
-
Flower
-
Oil and Tinctures
-
-
-
Derivatives Outlook (Revenue, USD Million, 2021 - 2033)
-
CBD
-
THC
-
Others
-
-
Cultivation Outlook (Revenue, USD Million, 2021 - 2033)
-
Indoor Cultivation
-
Greenhouse Cultivation
-
Outdoor Cultivation
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Industrial Use
-
Medical Use
-
Chronic Pain
-
Depression and Anxiety
-
Arthritis
-
Post Traumatic Stress Disorder (PTSD)
-
Cancer
-
Migraines
-
Epilepsy
-
Alzheimer’s
-
Multiple Sclerosis
-
AIDS
-
Amyotrophic Lateral Sclerosis
-
Tourette’s
-
Diabetes
-
Parkinson's
-
Glaucoma
-
Others
-
-
Recreational Use
-
Frequently Asked Questions About This Report
b. Key factors that are driving the market growth include growing adoption of cannabis for therapeutic purposes and imminent legalization of recreational marijuana.
b. Some key players operating in the New York cannabis market include Curaleaf Holdings, Inc., New York Hemp Oil, COOKIES CREATIVE PRODUCTIONS & CONSULTING, INC., ACREAGE HOLDINGS., Cannabist Company Holdings Inc., Cresco Labs., PharmaCann Inc., Vireo Health International, Inc., Green Thumb Industries (GTI)
b. The New York legal cannabis market size was estimated at USD 2.52 billion in 2025 and is expected to reach USD 2.82 billion in 2026.
b. The New York cannabis market is expected to grow at a compound annual growth rate of 11.5% from 2026 to 2033 to reach USD 6.06 billion by 2033.
b. By end use, the recreational use segment dominated the market in 2025 with a revenue share of 66.7% and is expected to grow at fastest CAGR over the forecast period. Recreational use of cannabis includes smoking and consuming it in the form of foods & beverages, vapes, and gummies.
Share this report with your colleague or friend.
Need a Tailored Report?
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.